Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells

E. Jabbari, M. L. Ceridon, T. E. Hefferan, L. G. Pedersen, Lichun Lu, B. L. Currier, Michael J Yaszemski

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The cytocompatibility of poly(caprolactone fumarate) (PCLF) which is used for filling the bone defects was investigated. PCLF was developed by copolymerization of fumaryl chloride (FC) with poly(caprolactone) (PCL) that self-linked in the absence of a crosslinking agent. The PCLF scaffolds were salt leached to form a three-dimensional porous and interconnected scaffold. The results showed that the self-crosslinking linear PCLF and the crosslinked PCLF scaffolds are compatible with human fetal osteoblast cells.

Original languageEnglish (US)
Title of host publicationTransactions - 7th World Biomaterials Congress
Pages1061
Number of pages1
StatePublished - 2004
EventTransactions - 7th World Biomaterials Congress - Sydney, Australia
Duration: May 17 2004May 21 2004

Other

OtherTransactions - 7th World Biomaterials Congress
CountryAustralia
CitySydney
Period5/17/045/21/04

Fingerprint

Osteoblasts
Scaffolds
Crosslinking
Forms (concrete)
Copolymerization
Bone
Salts
Defects

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Jabbari, E., Ceridon, M. L., Hefferan, T. E., Pedersen, L. G., Lu, L., Currier, B. L., & Yaszemski, M. J. (2004). Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells. In Transactions - 7th World Biomaterials Congress (pp. 1061)

Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells. / Jabbari, E.; Ceridon, M. L.; Hefferan, T. E.; Pedersen, L. G.; Lu, Lichun; Currier, B. L.; Yaszemski, Michael J.

Transactions - 7th World Biomaterials Congress. 2004. p. 1061.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Jabbari, E, Ceridon, ML, Hefferan, TE, Pedersen, LG, Lu, L, Currier, BL & Yaszemski, MJ 2004, Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells. in Transactions - 7th World Biomaterials Congress. pp. 1061, Transactions - 7th World Biomaterials Congress, Sydney, Australia, 5/17/04.
Jabbari E, Ceridon ML, Hefferan TE, Pedersen LG, Lu L, Currier BL et al. Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells. In Transactions - 7th World Biomaterials Congress. 2004. p. 1061
Jabbari, E. ; Ceridon, M. L. ; Hefferan, T. E. ; Pedersen, L. G. ; Lu, Lichun ; Currier, B. L. ; Yaszemski, Michael J. / Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells. Transactions - 7th World Biomaterials Congress. 2004. pp. 1061
@inproceedings{b6bdb0a75fa94023bf3e657a497792c3,
title = "Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells",
abstract = "The cytocompatibility of poly(caprolactone fumarate) (PCLF) which is used for filling the bone defects was investigated. PCLF was developed by copolymerization of fumaryl chloride (FC) with poly(caprolactone) (PCL) that self-linked in the absence of a crosslinking agent. The PCLF scaffolds were salt leached to form a three-dimensional porous and interconnected scaffold. The results showed that the self-crosslinking linear PCLF and the crosslinked PCLF scaffolds are compatible with human fetal osteoblast cells.",
author = "E. Jabbari and Ceridon, {M. L.} and Hefferan, {T. E.} and Pedersen, {L. G.} and Lichun Lu and Currier, {B. L.} and Yaszemski, {Michael J}",
year = "2004",
language = "English (US)",
isbn = "1877040193",
pages = "1061",
booktitle = "Transactions - 7th World Biomaterials Congress",

}

TY - GEN

T1 - Evaluation of the cytocompatibility of a novel poly(caprolactone fumarate) injectable scaffold with human fetal osteoblast cells

AU - Jabbari, E.

AU - Ceridon, M. L.

AU - Hefferan, T. E.

AU - Pedersen, L. G.

AU - Lu, Lichun

AU - Currier, B. L.

AU - Yaszemski, Michael J

PY - 2004

Y1 - 2004

N2 - The cytocompatibility of poly(caprolactone fumarate) (PCLF) which is used for filling the bone defects was investigated. PCLF was developed by copolymerization of fumaryl chloride (FC) with poly(caprolactone) (PCL) that self-linked in the absence of a crosslinking agent. The PCLF scaffolds were salt leached to form a three-dimensional porous and interconnected scaffold. The results showed that the self-crosslinking linear PCLF and the crosslinked PCLF scaffolds are compatible with human fetal osteoblast cells.

AB - The cytocompatibility of poly(caprolactone fumarate) (PCLF) which is used for filling the bone defects was investigated. PCLF was developed by copolymerization of fumaryl chloride (FC) with poly(caprolactone) (PCL) that self-linked in the absence of a crosslinking agent. The PCLF scaffolds were salt leached to form a three-dimensional porous and interconnected scaffold. The results showed that the self-crosslinking linear PCLF and the crosslinked PCLF scaffolds are compatible with human fetal osteoblast cells.

UR - http://www.scopus.com/inward/record.url?scp=13844297948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844297948&partnerID=8YFLogxK

M3 - Conference contribution

SN - 1877040193

SN - 9781877040191

SP - 1061

BT - Transactions - 7th World Biomaterials Congress

ER -